Morgan Stanley’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.4M | Buy |
5,339,654
+2,658,456
| +99% | +$9.68M | ﹤0.01% | 2840 |
|
|
2025
Q1 | $5.15M | Buy |
2,681,198
+891,147
| +50% | +$1.71M | ﹤0.01% | 3899 |
|
|
2024
Q4 | $3.4M | Buy |
1,790,051
+701,159
| +64% | +$1.33M | ﹤0.01% | 4305 |
|
|
2024
Q3 | $1.44M | Buy |
1,088,892
+325,560
| +43% | +$430K | ﹤0.01% | 4842 |
|
|
2024
Q2 | $779K | Sell |
763,332
-25,043
| -3% | -$25.5K | ﹤0.01% | 5105 |
|
|
2024
Q1 | $1.44M | Sell |
788,375
-559,183
| -41% | -$1.02M | ﹤0.01% | 4759 |
|
|
2023
Q4 | $1.67M | Buy |
1,347,558
+935,729
| +227% | +$1.16M | ﹤0.01% | 5020 |
|
|
2023
Q3 | $469K | Buy |
411,829
+37,205
| +10% | +$42.4K | ﹤0.01% | 5193 |
|
|
2023
Q2 | $343K | Sell |
374,624
-269,493
| -42% | -$247K | ﹤0.01% | 5406 |
|
|
2023
Q1 | $361K | Buy |
644,117
+302,988
| +89% | +$170K | ﹤0.01% | 5439 |
|
|
2022
Q4 | $197K | Sell |
341,129
-6,389
| -2% | -$3.69K | ﹤0.01% | 5676 |
|
|
2022
Q3 | $110K | Sell |
347,518
-309,021
| -47% | -$97.8K | ﹤0.01% | 6027 |
|
|
2022
Q2 | $232K | Sell |
656,539
-339,175
| -34% | -$120K | ﹤0.01% | 5821 |
|
|
2022
Q1 | $714K | Sell |
995,714
-200,500
| -17% | -$144K | ﹤0.01% | 5191 |
|
|
2021
Q4 | $2.7M | Sell |
1,196,214
-277,291
| -19% | -$627K | ﹤0.01% | 4332 |
|
|
2021
Q3 | $4.24M | Sell |
1,473,505
-1,186,868
| -45% | -$3.42M | ﹤0.01% | 3907 |
|
|
2021
Q2 | $10.1M | Sell |
2,660,373
-680,337
| -20% | -$2.58M | ﹤0.01% | 2973 |
|
|
2021
Q1 | $11.3M | Buy |
3,340,710
+3,080,193
| +1,182% | +$10.4M | ﹤0.01% | 2521 |
|
|
2020
Q4 | $729K | Sell |
260,517
-940,739
| -78% | -$2.63M | ﹤0.01% | 4843 |
|
|
2020
Q3 | $3.01M | Buy |
1,201,256
+986,634
| +460% | +$2.48M | ﹤0.01% | 3251 |
|
|
2020
Q2 | $2.91M | Buy |
214,622
+37,240
| +21% | +$506K | ﹤0.01% | 3219 |
|
|
2020
Q1 | $1.35M | Sell |
177,382
-808,653
| -82% | -$6.14M | ﹤0.01% | 3713 |
|
|
2019
Q4 | $6.23M | Sell |
986,035
-33,635
| -3% | -$213K | ﹤0.01% | 2945 |
|
|
2019
Q3 | $4M | Sell |
1,019,670
-188,721
| -16% | -$740K | ﹤0.01% | 3112 |
|
|
2019
Q2 | $5.85M | Sell |
1,208,391
-119,137
| -9% | -$577K | ﹤0.01% | 2757 |
|
|
2019
Q1 | $10.9M | Buy |
1,327,528
+293,620
| +28% | +$2.4M | ﹤0.01% | 1963 |
|
|
2018
Q4 | $5.72M | Sell |
1,033,908
-853,528
| -45% | -$4.72M | ﹤0.01% | 2737 |
|
|
2018
Q3 | $16.7M | Buy |
1,887,436
+496,069
| +36% | +$4.38M | ﹤0.01% | 1862 |
|
|
2018
Q2 | $13.9M | Buy |
1,391,367
+217,504
| +19% | +$2.17M | ﹤0.01% | 2015 |
|
|
2018
Q1 | $11.2M | Buy |
1,173,863
+406,975
| +53% | +$3.88M | ﹤0.01% | 2244 |
|
|
2017
Q4 | $11.4M | Buy |
766,888
+54,516
| +8% | +$811K | ﹤0.01% | 2278 |
|
|
2017
Q3 | $14M | Buy |
712,372
+9,667
| +1% | +$190K | ﹤0.01% | 1933 |
|
|
2017
Q2 | $10.1M | Sell |
702,705
-167,737
| -19% | -$2.41M | ﹤0.01% | 2183 |
|
|
2017
Q1 | $8.01M | Buy |
870,442
+55,369
| +7% | +$509K | ﹤0.01% | 2419 |
|
|
2016
Q4 | $8.48M | Buy |
815,073
+477,567
| +141% | +$4.97M | ﹤0.01% | 2435 |
|
|
2016
Q3 | $3.05M | Buy |
337,506
+116,001
| +52% | +$1.05M | ﹤0.01% | 3148 |
|
|
2016
Q2 | $1.66M | Sell |
221,505
-12,243
| -5% | -$91.5K | ﹤0.01% | 3580 |
|
|
2016
Q1 | $2.11M | Buy |
233,748
+134,602
| +136% | +$1.21M | ﹤0.01% | 3308 |
|
|
2015
Q4 | $1.28M | Sell |
99,146
-13,763
| -12% | -$178K | ﹤0.01% | 3866 |
|
|
2015
Q3 | $1.09M | Buy |
112,909
+64,722
| +134% | +$625K | ﹤0.01% | 4035 |
|
|
2015
Q2 | $496K | Sell |
48,187
-7,638
| -14% | -$78.6K | ﹤0.01% | 4713 |
|
|
2015
Q1 | $620K | Sell |
55,825
-67,710
| -55% | -$752K | ﹤0.01% | 4501 |
|
|
2014
Q4 | $1.44M | Sell |
123,535
-179,377
| -59% | -$2.09M | ﹤0.01% | 3840 |
|
|
2014
Q3 | $6.7M | Sell |
302,912
-93,937
| -24% | -$2.08M | ﹤0.01% | 2378 |
|
|
2014
Q2 | $11M | Buy |
+396,849
| New | +$11M | ﹤0.01% | 1947 |
|